Clinical Trial Update: Study to Determine the Amount of Glycopyrrolate Absorbed in the Lungs After Taking the Medicine With a eFlow Nebulizer and Seebri® Breezhaler® With and Without Activated Charcoal in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD). [Phase 1]

View source ↗

Summary

Phase 1 trial updating the absorption of glycopyrrolate in the lungs when administered with eFlow nebulizer and Seebri Breezhaler, with and without activated ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Seebri Breezhaler (glycopyrronium bromide)

Snippet

Sponsor: Sunovion Respiratory Development Inc. | Conditions: COPD | Phase 1 | Status: COMPLETED | Results posted: 2018-09-14